Mumbai, India
+91 22 28560031

About Us

Welcome to Innorex

Headquartered in Mumbai, India, Innorex’s business is broadly divided into three verticals viz. Active Pharmaceutical Ingredients (API), Finished Formulations and Services

Innorex’s business model is based on strategic partnerships and collaborations for offering products & services tailor made to our customers requirements across various geographies.

Need Help ?

Active Pharmaceutical Ingredients

Innorex has the expertise to source Active Pharmaceutical Ingredients, Intermediates, Fine Chemicals, Excipients, Phytochemicals and Diagnostic Products from reputed manufacturers having WHO GMP, cGMP and ISO certification.

Inorder to meet the current regulatory requirements, Innorex, along with its partner manufacturers, has been offering APIs along with all the necessary regulatory documents including Drug Master Files and Certificate of Suitability for select APIs.

Finished Formulations

Innorex offers a wide range of generic, branded generic, OTC, nutraceutical, herbal and diagnostic products across various therapeutic categories viz. oncology, diabetes, cardiology, pain management, anti-infectives etc.

Innorex also has a very efficient marketing infrastructure in Kenya where it is marketing anti-cancer products and other hospital based products. Innorex’s marketing personnel have a pan-Kenya coverage and have excellent relationship with Key Opinion Leaders be it doctors, para medical personnel and pharmacist. Innorex also has a well established distribution network covering almost all the pharmacies, hospitals, clinics etc. Innorex intends to replicate the success it has achieved in Kenya in various other markets globally by following the best practices in marketing, sales and distribution.

Innorex has partnerships and collaborations with

R & D centres having scientists skilled in innovative and cost effective technologies for development of NDDS, difficult to formulate products, generics and branded generics. Further to this the finished formulations offered by Innorex are backed by dossiers as per EU-CTD, A-CTD or the regulatory guidelines of the country in which the products are to be marketed.

CRO’s having the expertise in carrying out analytical studies, stability studies, BA BE studies as per ICH guidelines as well as Phase I – Phase IV clinical trials.

Manufacturing facilities having state of the art equipment and certified by WHO, UK MHRA, MCC South Africa, TGA Australia and US FDA.

Our team of highly qualified & experienced personnel, co-ordinate with our collaborators/partners and ensure completion of development projects in a time bound manner, and also ensure manufacturing and supplies on time. Innorex also offers an efficient supply chain & logistic support for meeting delivery commitments.